PBMs, FTC and IRA: Experts Tackle Pharma’s Tough Acronyms At BioFuture

Some of the industry’s biggest challenges – and potential solutions to those problems – were hot topics at the BioFuture conference in New York.

(Shutterstock)

More from Drug Pricing

More from Business